University of Groningen Exploring the mechanisms underlying the phenotype of MCAD deficiency with Systems Medicine Martines, Anne-Claire
Hele tekst
(2) Chapter 2 The promiscuous enzyme medium-chain 3-keto-acyl-CoA thiolase triggers a vicious cycle in fatty-acid beta-oxidation. Anne-Claire M.F. Martines1,2, Karen van Eunen1,2, Dirk-Jan Reijngoud1,2, and Barbara M. Bakker1,2,*. 1 Laboratory. of Pediatrics, University of Groningen, University Medical Center Groningen, The Netherlands 2 Systems Biology Centre for Energy Metabolism and Ageing, University of Groningen, University Medical Center Groningen, The Netherlands. PLoS Comput Biol. 2017;13(4):1–22.
(3)
(4) The promiscuous enzyme MCKAT triggers a vicious cycle in fatty-acid beta-oxidation. Abstract Ǧ Ǧ ȋ Ȍ Ǥ Ǥ
(5) Ǥ ǡ ǡ Ǯ ǯȋ ȌǤ
(6) ǡ Ǥ ǡ Ǥ Ǥ ǡ Ǧ Ǧ ȋȌǡ Ǥǡ Ǥ ǡ ǡ Ǥǡǯ Ǧ Ǥ ǡ ȀǦ Ǧ ǡ ǡ ǡ ǦǤ Ǧ Ǥ ǡ Ǥ ǡ ǡ Ǥ ǡ Ǯ ǯǤ Ǥ . Ͷͳ. 2.
(7) Chapter 2. Introduction Ǧ ȋ Ȍ Ǥ
(8) ǡ ǡ Ǧ Ǥ ǡ Ǥ ǡ ȏͳǡʹȐǤ Ǯ ǯǡ Ǧ ȏͳǡʹȐǤ ǡ ǡ Ǥ ǡ ǦǦ Ǧ Ǧ ȋȌ Ǧ ǡ ȏ͵ȂȐǤ ǡ Ǧ Ǧ Ǧ ȏȐǤ
(9) ǡ ǡ ǡ Ǥ ǡ ȏͺȐǤ ǦǡǦ ȋͳȌǡ Ǧ Ǥ ǡ Ǧ ȋȌ Ǥ Ǧ ȏͻȐǡ ǡ ȏͻȐǤ ǡ ǡ Ǧ Ǥǡ ǡ ǡ ȏͳͲȐǤ ǡ ǡ ǡ Ǥ ǡ Ǧ ȏʹǡͺȐǤǦ Ǧ ȋ ͳȌǤ
(10) ǡ Ǧ Ǧ Ǥ Ǧ ȋǤǤ ͳǤ͵ǤͻͻǤ͵ ǤǤͳǤ͵ǤͺǤͳȌǡǦ ȋǡǤǤͶǤʹǤͳǤͶǤǤͶǤʹǤͳǤͳͷͲȌǡ ǦȋǤǤͳǤͳǤͳǤʹͳͳǤǤͳǤͳǤͳǤ͵ͷȌ Ǧ ȋǤǤ ʹǤ͵ǤͳǤͳȌȌǤ ȋ ǦǦǡ Ǧǡ Ǧǡ Ǧ Ǧ ǡǡǡȌ ǡ Ǧǡ Ǥ Ͷʹ.
(11) The promiscuous enzyme MCKAT triggers a vicious cycle in fatty-acid beta-oxidation. Malonyl-CoA Palmitoyl-CoA Palmitoyl-carnitine carnitine CoASH carnitine. 2. CPT1 CACT. C16. CPT2. C4-C16. Mitochondrion. C4-C16. carnitine. CoASH carnitine. Palmitoyl-carnitine Acyl-CoA. MCKAT. Acetyl-CoA. SCAD. MCAD. LCAD. VLCAD. C4-C16. CoASH. C4-C6. C4-C12. C8-C16. C12-C16. Enoyl-CoA. Ketoacyl-CoA. MSCHAD C4-C16. NADH + H+ C4-ketoacyl-CoA NAD+. CROT C4-C16. FAD FADH2. Acetyl-CoA NADH + H+ C4-ketoacyl-CoA NAD+ CoASH. MTP C8-C16. Hydroxyacyl-CoA. Fig 1. Schematic representation of the modelled mFAO pathway in rat. ǡǤ Ǥ ǣ Ǣ ǣ Ǧ Ǣǣ ǦǦ Ǥ Ǥ ȏͺȐǡ Ǥ. ȋȌ ͺ ǡȋͶȌ ǡ ȀǦ Ǧ ȋȀ Ȍǡ Ǧ Ǧ ȋȌǤ ǡ Ǥ
(12) ȏͺȐǡ ǡǤǤ Ǥ Ǥ ǡ Ǧ ǡ Km Ǥ ǡ ͳǦ Ǧ ǡǣ ሾಷಲವሿ ሾభలషೌషಲሿ ሾభలషషಲሿ ሾಷಲವಹమሿ ή ି ή ಼ೇಽಲವǡభలషೌషಲ ಼ೇಽಲವǡಷಲವ ಼ೇಽಲವǡభలషೌషಲ ಼ ೇಽಲವǡಷಲವήܭ. ௦ೇಽಲವǡభల ήೌೣǡೇಽಲವ ήቌ. ቍ. ݁ݍǡܸܦܣܥܮ. ݒǡଵ ൌ. ሾಷಲವሿ ሾభలషೌషಲሿ ሾభలషషಲሿ ሾషೌషಲሿ ሾషషಲሿ ሾಷಲವಹమ ሿ ۊήቆଵା ା ା σసభర ା ା ቇ సభమ಼ ಼ೇಽಲವǡಷಲವ ಼ೇಽಲವǡಷಲವಹ ಼ೇಽಲವǡభలషೌషಲ ಼ೇಽಲವǡభలషషಲ ೇಽಲವǡషೌషಲ ಼ೇಽಲವǡషషಲ ᇣᇧᇧᇧᇧᇧᇧᇧᇧᇤᇧᇧᇧᇧᇧᇧᇧᇧᇥ ᇣᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇤᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇧᇥ మ ್್ೝೌೝೠ ್್ೞೠ್ೞೝೌೞೌೝೠೞೝೌೞی. ۇଵା ۉ. ȋͳȌ
(13) ǡ Ǥ
(14) in silico ȋǤǤ Ȍǡ Ǥ . Ͷ͵.
(15) Chapter 2 ȏͺǡͻȐǤ How ǡǡǤ ǡ Ǥ Ǥ Ǥ ǡ ȋȌ ȋȌ Ǥ ȏͳͳȐǡ ȏͳʹȐǤ Ǥ Ǥ . Results Description of the phenotype
(16) Ǧ ȋȏǦȐȌȋ ʹȌǡ ȋ ʹȌǤ B 2.0. 6000. 1.6. 5000. free CoA. [Metabolite] (ȝM). Juptake (μmol.min-1.gProtein-1). A. 1.2. 0.8 0.4. 4000. Intermediate CoA esters. 3000. C6/C4 CoA esters. 2000. C4-CoA esters. 1000. C6-CoA esters. 0. 0.0 0. 0. 250. D. 8. vmtpC8 vmtpC10 vmtpC12 vmtpC14 vmtpC16. 7 6 5 4 3. 2 1. 8. J (μmol.min-1.gProtein-1). J (μmol.min-1.gProtein-1). C. 50 100 150 200 [Palmitoyl-CoA]CYT (ȝM). 50 100 150 200 250 [Palmitoyl-CoA]CYT (ȝM). vmckatC4 vmckatC6 vmckatC8 vmckatC10 vmckatC12 vmckatC14 vmckatC16. 7 6 5 4 3 2 1 0. 0. 0. 50 100 150 200 250 [Palmitoyl-CoA]CYT ȝ0
(17). 0. 50 100 150 200 [Palmitoyl-CoA]CYT ȝ0
(18). 250. . Fig 2. Simulated steady-state fluxes and concentrations in the mFAO model. (A) Ǧ ȋȏǦȐȌ Ǧ Ǥ Ǧ Ǧȋ Ȍȋ Ǧ Ǧ . ͶͶ.
(19) The promiscuous enzyme MCKAT triggers a vicious cycle in fatty-acid beta-oxidation ǡǤǤǦ Ȍǡ et al. ʹͲͳ͵ ȏͺȐ Ǥ Ǧ Ǥ (B) Ǧ ȋ ȏͺȐȌǡ ǡ ͶǦ ͶǦ ȋ ȌǤ (C-D) Ǧ ȋ Ȍ Ǧ ǡ Ǥ ȋ Ǥ ͳȌ Ǥ. ǡ Ͷ ȋ ʹȌǤ Ǧ ǣ ȋ ͳȌǡ ͺ ǡ Ǧ Ȁ Ǧ ȋ ͳȌǡ ͶͳǤǡͶǦ ǦȀ Ǧ ǡ Ǥ ǡ ͺ Ǧ ȋ ʹȌǤ Ͷ ǡ ǡǦȀ Ǧ ȋ ʹȌǤǡ Ǧ Ǥ Ǧ Ǥ. The flux decline originates at the promiscuous MCKAT enzyme ǡ Ǥ ǡ Ȃ Ȃ ȋȌǤ
(20) Ǧ ǡ ǡ Ǥ ȋVmaxȌ ȋ ȌǤ ȋ ͵ȌǤ
(21) ǡ ǡ Ǧ ȋ ͵ȌǤ
(22) ǡ ȋ ͳ Ȍǡ ȋ ͵ȌǤǡ exceptǡ ȋ ͵ȌǤȂ Ǧ ͷͲ ρ ǦǤ ǡ Ǧ ʹͷͲρǡ ȋͳ ȌǤ
(23) ǡǦ ȋ ͵ȌǤ ǡ ǡ Ǥ Ͷͷ. 2.
(24) Chapter 2 B 4. 2.0 1.6. Published model. 1.2. No promiscuity at MCKAT. 0.8. Flux control coefficient (-). No promiscuity except at MCKAT. 0.4. No promiscuity. CPT1 2 MCAD. 0 SCAD -2 MCKAT -4. 0.0. 0. 50 100 150 200 250 [Palmitoyl-CoA]CYT ȝ0
(25). C. D. J. Rpuptake -2.5. sfcpt1C16 Vcpt1 CarCYT Kmcpt1CarCYT CoACYT Kmcpt1CoACYT C16AcylCoACYT Kmcpt1C16AcylCoACYT Keqcpt1 Keqcact Vfcact sfcactC16 [NAD+]/[NADH] Vmckat Keqmschad. 0.0. 50 100 150 200 250 [Palmitoyl-CoA]CYT (ȝM). E. J. -2.5. 2.5. Rpuptake 0.0. 2.5. Keqmschad Vmckat [NAD+]/[NADH] CoACYT Keqcrot sfmckatC4 sfcpt1C16 Vcpt1 KmmckatC4ketoacylCoA Kmcpt1CarCYT CarCYT Kmcpt1CoACYT C16AcylCoACYT KmmckatC4acylCoA KmmckatCoAMAT. Juptake. 0. Reaction-partitioned R[NAD+ ]/[NADH]. Juptake (μmol.min-1.gProtein-1). A. 3. vmschadC4 vmschadC6. 2. vmtpC8 vmtpC10. 1. vmtpC12 vmtpC14. 0. vmtpC16. -1 5. 15. 25 53.37 60. 250. [Palmitoyl-CoA]CYT (μM). . Fig 3. The role of the short-chain branch. (A) Ǧ ȏǦȐ ȋ Ȍǡ ȋ ǡ ȏͺȐ Ȍǡ ȋȌǡ ǡȋȌǤ (B) ȏǦȐǤ Ǣ ǡ ʹ Ǥ(C-D) ͳͷ ʹͷɊȋȌͲɊȋȌȏǦ ȐǤp ǦǤ ͳǦ ǡ Ȁ Ǧ ǡ Ǧ Ǧ ୳୮୲ୟ୩ୣ. Ǥ(E) ȏΪȐȀȏ Ȑȋ ሾୈశሿȀሾୈୌሿ Ȍ . ΪǦ ͷǦ ܴሾே శ ሿȀሾேுሿ ൌ ௩. ୳୮୲ୟ୩ୣ. σ ܥ ή ߝሾே శ ሿȀሾேுሿ . (cf. Eq. 4). Ȁ ͺǦͳ ሾୈశ ሿȀሾୈୌሿ . Ǥ. . MCKAT becomes the most important flux-controlling enzyme when the flux declines Ǧͳǡǡ ͳǡǡʹȋ ͳȌǤ Ǧ ͳ Ǥ ǡ Ǥ
(26) ȏͳͳǡͳ͵ȂͳͷȐǡ ܥ iǦJ ǣ ܥ ൌ. ௗȀௗ డ௩Τడ. ȋʹȌ. p viǤ ͳ p ȋǤǤ VmaxȌ ǦǤ
(27) Ͷ.
(28) The promiscuous enzyme MCKAT triggers a vicious cycle in fatty-acid beta-oxidation ǡ Ǧ Ǥ p ǡ Ǧ Ǥ ͵Ǥ Ǧ ͳ ǡ ͳǡ ȋ ͵ ʹȌǤǦ ǡǡ ͳ ǡ Ǥ ȏͳͳǡͳͶȐ ͳǡ ͳ Ǥ ǡ ȋ ͵ ʹȌǤ ǡ ǦǦ Ͷ ȋ ʹ Ȍǡ Ǧ Ǥ ȋʹ ȌǤ . The accumulation of intermediates is amplified by the short-chain branch ǡ ǡ ͳǡ ǡ Ǥ ǡ p Ǧ ǣ ȋʹͷɊȌ ȋͲɊȌǤ ܴ ȏͳͷȐ pǦ ǣ ܴ ൌ ݈݀݊ܬΤ݈݀݊ ȋ͵Ȍ ͵ ͵ ͳͷ ʹͷɊͲɊǦǡ Ǥ
(29) ͳǡ ʹͷρ ͳǡ ȋȌ Ǧ ȋǡ ǡ ͳ Ȍǡ ȋͳǡͳ ͳȌǡ ȋǡͳǡǡ ǡͳǡǡ ǡͳǡͳ Ȍ ȋ ͵Ȍǡ Ǥ Ͳ ρǡ ǡ ȋǤǤͶǡǡͶǡǡ ǡͶǦ Ǧǡǡ ǡͶǦ Ϊ ǦǡǡǡȌǤ
(30) ǡȏ ȐȀȏ Ȑ Ȁ ȋ Ȍ ȋ Ȍ Ͷ ȋ ͵ȌǤ Ϊ Ȁ ǡ ȏΪȐȀȏ Ȑ Ǥ Ǥ Ϊ ǡ Ȁ Ǧ Ǥǡ. Ͷ. 2.
(31) Chapter 2 ȏΪȐȀȏ Ȑ ǡ ȏͳͷȐǣ . ௩. ܴሾேశሿȀሾேுሿ ൌ σ ܥ ή ߝሾே శ ሿȀሾேுሿ. ȋͶȌ. iǡߝேାȀேு ȋǤǤ. Ȍ iΪǦ ǡ ǣ ௩. ା ߝሾே శ ሿΤሾேுሿ ൌ ߲݈݊ݒ Τ߲ሺሾܰ ܦܣሿΤሾܰܪܦܣሿሻ. ǤͶ Ǧ ܥ. ή. ȋͷȌ. ௩ ߝሾே శ ሿȀሾேுሿ ȋ ͵Ȍ. ǡͶ Ȁ Ǥ Ǥ ȏΪȐȀȏ Ȑ Ǧ ȋͶȌȀ ǡ Ǥ Ȁ ȋ ǤȀ ͵ ǡ ͵ ȌǤ ȏΪȐȀȏ Ȑ ǡ Ǥ Ȁ ʹǤͳȉͳͲǦͶȋǡ Ǥ ͳȌ Ǥ ͶǦ Ǧǡ ǡ Ǧ Ȁ ǡ ȏΪȐȀȏ Ȑ ȋ ͵ ȌǤ ͵Ǥͳ͵ǡ Ǧ ȋ ͵ ȌǤǡȀ ǡ Ǥ ǡ ͵ Ͷ ȋǤǤ ǡͶǡ ǡ ǡͶǦ ǦȌǡ ǡ ͶǦ Ǧ ȋǤǤ ǡ ǡͶǦ ǦȌǡ Ǥ Ͷ ǡ ȋȌ ͶǦ ȋͶǡ ǦǦ Ȍ ʹǦ Ǧ ȋȌ ȋͲǤͶͻ ͳȌ ȋȌ ʹǦ ͶǦ ǦǦ Ǧǡ ʹǦ Ǧ ȋȌȋͳʹǤͶǤɊȌǤ . Internal regulation reveals a vicious cycle around MCKAT ǡ Ǥ ͲǤͳ ρǡ Ǧ ʹͷ Ͳ ρ Ǥ ǡ . Ͷͺ.
(32) The promiscuous enzyme MCKAT triggers a vicious cycle in fatty-acid beta-oxidation Ǧȋ Ͷ ȌǤ ǦȋʹͷρȌ ȋ ͷ ȌǤ Ͳ ρǡ ǡ ǡ Ͷȋ ͶȌǤ A. B vMCKATC6 vMCADC4 + vSCADC4 vMCKATC4. 1.4 1.3 1.2 1.1. 0.01. vmckatC4 ĬX j (μmol.miní2.mgProteiní). v (μmol.min-1.gProtein-1). 1.5. C16-Ketoacyl-CoA C14-Ketoacyl-CoA C12-Ketoacyl-CoA C10-Ketoacyl-CoA C8-Ketoacyl-CoA C6-Ketoacyl-CoA C4-Ketoacyl-CoA C16-Acyl-CoA C14-Acyl-CoA C12-Acyl-CoA C10-Acyl-CoA C8-Acyl-CoA C6-Acyl-CoA C4-Acyl-CoA Free CoA. 0. -0.01. 0.0 0. 100 200 time (min). 300. 0. 100. 200 time (min). 300. . Fig 4. Time course of key short-chain reaction rates and regulation of the MCKAT-C4 reaction. (A) Ͷ ȋ Ͷǡ Ȍ Ͷ ȋͶ Ϊ ͶȌȏǦȐͲǤͳͲɊǤ(B) ͶȏǦȐ ͲǤͳͲɊǤ . ͶǦ Ǧ ͶǦ Ǧ Ǧ Ǥ ǡ ʹͺ ǡ Ǥ Ȁ ǡȋ ȌǤ Ǥ Ǥ ǡ ǡ Ǥ ʹͲͲͷ ȏͳʹȐǤ v Xj ǡ j ǣ ௗ௩ ሺݐሻ ௗ௧. ൌ σ. ௗೕ డ௩ ሺݐሻ ή ሺݐሻ ௗ௧ డೕ. ȣ௩ ೕ ሺݐሻ ؠ. ǣ. ؠσ ȣ௩ ೕ ሺݐሻ. ȋȌ. ௗೕ డ௩ ሺݐሻ ή ௗ௧ ሺݐሻ డೕ. ȋȌ.
(33) 4ఫ തതത ଵ ௧ ௗ௩ ሺ߬ሻ݀߬ ௧ ௗ௧. Xjǣ ଵ ௧ σ ȣ௩ ೕ ሺ߬ሻ݀߬ ௧. . . . ഥ ௩ ൌ σ ȣ ೕ. . . . ଵ. ௧ డ௩. ൌ σ ሺ߬ሻ ή ௧ డ. ௗೕ ௗ௧. ೕ. . . . ሺ߬ሻ݀߬ ൌ. . . ȋȌ. ǣ. Ͷͻ. 2.
(34) Chapter 2 ഥ ȁ௩ ൌ ଵ ௧ ቚȣ௩ ሺ߬ሻቚ ݀߬ ȁȣ ೕ ೕ ௧ . ȋͺȌ. Ͷ ȣ௩ ೕ ሺݐሻ ͶǦ Ǧ ͲǤͳͲρ Ǧǡ Ǥ Ǥ ഥ ȁ௩ெ்ିସ j ȁȣ ೕ Ͷ Ǥ ͶǦ ǦǤ Ǧ ǡ Ǥ Ǥ . డ௩ಾ಼ಲషర డ୪୬ሾሿ. ǡ ǡ. Ǥ
(35) ͷǦ ǦͲǤͳρ ǦǤ ͶǦ Ǧǡ ȋ ͷȌǤͲǤͳͲ ρǡ Ǧ Ǧ ȋǤǤͶǦ Ǧ ͶǦ Ǧ Ǧ Ǧ Ȍǡ Ǧ ǡ Ǧ ǡ Ǧ Ǥ Ǧ ǡ ȋ ȌǤ Ǧ Ǥ Ǧ Ǥ ǡ Ǧ ͶǤ ǦͶǦ ǦǦ Ǧ ͶǦ Ǥ ǡ ȋ ȌǤǦ Ǧ ǡ Ǧ Ǧ ǦǤǦͶǦ ǦǦ ǡ Ǥ ǯ ͶǦ Ǧ ǦǤ ǡ Ǧǡ ǦǦǤ Ǧ Ǧ Ǥ Ǧ Ǥ Ǥǡ Ǥ Ǧǡ Ǥ
(36) ȋ ͶȌ Ǧ Ǧȋ ͶȌǤ Ǧ. ͷͲ.
(37) The promiscuous enzyme MCKAT triggers a vicious cycle in fatty-acid beta-oxidation ǡ Ǧ ȋ ͺ ȌǤ
(38) ǡ ͶǦ Ǧ Ǧǡ ǤͶ Ψ Ͳ ρ Ǧȋ ͺ ȌǤ A. j  ഥ |v σj |Ĭ Xj. ഥ |v |Ĭ X. B. vMCKATC6. 100% 75% 50%. C6-ketoacyl-CoA (substrate). 25% 0% 0. 50. 100. 150. 200. vMCKATC4. Free CoA C4-Acyl-CoA C6-Acyl-CoA C8-Acyl-CoA C10-Acyl-CoA C12-Acyl-CoA C14-Acyl-CoA C16-Acyl-CoA C4-Ketoacyl-CoA C6-Ketoacyl-CoA C8-Ketoacyl-CoA C10-Ketoacyl-CoA C12-Ketoacyl-CoA C14-Ketoacyl-CoA C16-Ketoacyl-CoA. Free CoA. C4-ketoacyl-CoA (substrate). 0. 250. [Palmitoyl-CoA]CYT ȝ0
(39). C. D. j  ഥ |v σj |Ĭ Xj. ഥ |v |Ĭ X. 50% C6-acyl-CoA (substrate). 0% 0. 50. 100. 150. 200. 0. j  ഥ |v σj |Ĭ Xj. ഥ |v |Ĭ X. F. 50%. C8-enoyl-CoA (substrate). 0% 50. 100. 150. 50. 200. C4-Enoyl-CoA C6-Enoyl-CoA C4-Acyl-CoA C6-Acyl-CoA. 100. 150. 200. 250. vCPT2C16. Free CoA C4-Ketoacyl-CoA C6-Acyl-CoA C8-Acyl-CoA C10-Acyl-CoA C12-Acyl-CoA C14-Acyl-CoA C16-Acyl-CoA C8-Enoyl-CoA C10-Enoyl-CoA C12-Enoyl-CoA C14-Enoyl-CoA C16-Enoyl-CoA. 75%. 0. 250. [Palmitoyl-CoA]CYT ȝ0
(40). Free CoA. 25%. 200. C4-acyl-CoA (substrate). 250. vMTPC8. 100%. 150. C4-enoyl-CoA. [Palmitoyl-CoA]CYT ȝ0
(41). E. 100. vSCADC4. C4-Enoyl-CoA C6-Enoyl-CoA C8-Enoyl-CoA C10-Enoyl-CoA C12-Enoyl-CoA C4-Acyl-CoA C8-Acyl-CoA C10-Acyl-CoA C12-Acyl-CoA C6-Acyl-CoA. 75%. 25%. 50. [Palmitoyl-CoA]CYT ȝ0
(42). vMCADC6 100%. Free CoA C4-Acyl-CoA C6-Acyl-CoA C8-Acyl-CoA C10-Acyl-CoA C12-Acyl-CoA C14-Acyl-CoA C16-Acyl-CoA C4-Ketoacyl-CoA C6-Ketoacyl-CoA C8-Ketoacyl-CoA C10-Ketoacyl-CoA C12-Ketoacyl-CoA C14-Ketoacyl-CoA C16-Ketoacyl-CoA. Free CoA. 250. [Palmitoyl-CoA]CYT ȝ0
(43). Free CoA C4-Acyl-CoA C6-Acyl-CoA C8-Acyl-CoA C10-Acyl-CoA C12-Acyl-CoA C14-Acyl-CoA C16-Acyl-CoA C4-Acyl-carnitine C6-Acyl-carnitine C8-Acyl-carnitine C10-Acyl-carnitine C12-Acyl-carnitine C14-Acyl-carnitine C16-Acyl-carnitine. Free CoA. C16-acyl-carnitine (substrate). 0. 50. 100. 150. 200. 250. [Palmitoyl-CoA]CYT ȝ0
(44). Fig 5.Regulation of key reactions by their substrates and products. (A-F) ഥ ȁ࢜ ȁࢨ ࢄ. ഥ ȁ࢜ ȁࢨ ࢄ. ǡǤǤ σ. ή Ψ,ͲǤͳɊ. Ǧǡ ȋȌǡͶȋȌǡ ȋȌǡͶȋȌǡͺȋȌǡʹͳȋ Ȍ.. ǡ Ǧǯ ͵ͲǤͶΨ Ǥ ǡ Ǧ ͳǤΨǤ ǡ Ǧ Ǥ ǡǡʹ Ǥ ǡ Ǧ ǡ ͷͳ. 2.
(45) Chapter 2 ͶǦ ǦǦ ȋ ͷ ȌǤ ǡ ȋ ͵ ȌǤ ͶǦǦ Ǧȋ ͺ ȌǤ Ǧ Ǥʹ ǡ ȋ ͷ ȌǤ . Discussion Ǧ Ǥ ǡ ȋ ȌǤ Palmitoyl-CoA. 5. Acyl-CoA. Mitochondrion 3.. MCKAT C4-C16 Ketoacyl-CoA. MSCHAD C4-C16 Keq = 0.0002. Acetyl-CoA 4.. CoASH. 2.. SCAD. MCAD. LCAD. C4-C6. C4-C12. VLCAD. 1.. Enoyl-CoA. NADH + H+ C4-ketoacyl-CoA NAD+ Hydroxyacyl-CoA. FAD FADH2. 2.. CROT. Acetyl-CoA. C4-C16. CoASH. MTP 5.. 2.. . Fig 6.Elucidating the mechanism of flux decline. 1. Ǧ ǡǯ Ǧ Ǥ 2. ǡ ȀǦ Ǧ ǡ ǡ ǡ ǦǤ3. Ǧ Ǥ4. ǡ Ǥ ǡ ǡ Ǥ5Ǥ ȋ Ȍǡ Ǯ ǯ Ǥ. ǡ ǡǡ Ǧ Ǥ substrates ȏͺȐǤ ǡ Ǥ ȏͻȐǤ Ǥ
(46) ǡǡ ǡǡȋǡ ͳȌȋȌ ȏͳȐǤ ǡ ǦǦ ͷʹ.
(47) The promiscuous enzyme MCKAT triggers a vicious cycle in fatty-acid beta-oxidation Ǧ ȏͳǡͳͺȐǡ Ǧ Ǥ ǡ Ǧ ǡ ȏͳͻȐǤ Ǧ Ǥ
(48) ǡ Ǧ Ǥ de novo Ǥ Ǥ ȋȌ Ǧ ǡ Ǧ Ǣ ȋȌ Ǧ Ȁ ȏ ΪȐȀȏ Ȑ Ǣ ȋȌ Ǥ Ǥ Ǥ MCKAT – Ǥ Ǧ ǡ ͳ ǡ ȏʹͲǡʹͳȐǤ ǡ ǡ Ǧ Ǥ
(49) ȾǦ ǡ ȏʹͳȐ Ǥ ȏʹʹǡʹ͵ȐǤ ȏʹͶȐǤ Ǥ ǡ Ͷ ǡ ȏʹͷȐǤ ǡ in vivoǤ
(50) ǡ ȏʹͷȐ SHC1 Ǥǡ ȋ Ȍ Ǧ Ǥ
(51) ȋʹȌ SHC1 Ǧ Ǥ M/SCHAD and the mitochondrial redox state – ȏΪȐȀȏ Ȑ ǤȏΪȐȀȏ Ȑ ǦǦ Ȁ Ǥ
(52) ǡ ǡ Ǥ. ͷ͵. 2.
GERELATEERDE DOCUMENTEN
Control Facility Affairs Human Resources Information Management Public Affairs Civil Affairs Taxes Legal Protection Commercial Affairs Central ICT Organization Financial
In section IV, we will show that the orbit of any graph state under local unitary operations within the Clifford group is generated by repeated application of essentially one
We consider this family of invariants for the class of those ρ which are the projection operators describing stabilizer codes and give a complete translation of these invariants
Construeer deze driehoek op juiste grootte (Maatlijn in centimeters was gegeven)..
The sample of 22 profes- sional people working in these areas was from the fields of health, social development, community development, education and safety and consisted
These characteristics can be based on the control-flow (e.g., the next activity going to be performed), the data-flow (e.g., the amount of money involved), the time perspective
However, this case study has also shown that further research is needed to develop process mining techniques that are particularly suitable for analyzing less structured processes
To solve the problems encountered with MXML and to create a standard that could also be used to store event logs from many different information systems directly, a new event log